Alan Levine / Flickr

Democratic presidential hopeful Bernie Sanders led a group of Americans on a bus ride from Detroit, Michigan to Windsor, Ontario last month to call attention to one of America's biggest health issues: the out of control cost of insulin.

According to the Centers for Disease Control, nearly 10% of Americans have diabetes and 7.4 million of them must take insulin to survive.

Keep Reading Show less
Well Being

In August 2016, pharmaceutical company Mylan became the latest health company to fall under fire for price gouging.

Over the course of seven years, they'd carefully managed to inflate the list price of EpiPen by nearly 500%, along with price-hikes on more than 30 other products too. That's pretty absurd, considering that some people, including fellow pharmaceutical-makers, say EpiPen ingredients are inexpensive and the pen can cost less than $20 to make. Plus, EpiPen already accounts for 40% of Mylan's operating profits.

At the height of this debacle, Mylan CEO Heather Bresch spoke with CNBC to offer insights on the inner workings of the pharmaceutical industry. And her answers actually revealed a lot about health care in America.

Keep Reading Show less
Family